Proposal for new diagnostic criteria for DIC from the Japanese Society on Thrombosis and Hemostasis

H Asakura, H Takahashi, T Uchiyama, Y Eguchi… - Thrombosis …, 2016 - Springer
Disseminated intravascular coagulation (DIC) is a serious disease that, in the presence of
underlying disease, causes persistent, generalized, marked coagulation activation. Early …

Disseminated intravascular coagulation in hematologic malignancies

M Franchini, MND Di Minno… - Seminars in thrombosis …, 2010 - thieme-connect.com
Disseminated intravascular coagulation (DIC) significantly contributes to the bleeding and
thrombotic complications in patients with hematologic malignancies. As shown in other …

Increase of classic and nonclassic cardiovascular risk factors in patients with acromegaly

L Vilar, LA Naves, SS Costa, LF Abdalla, CE Coelho… - Endocrine Practice, 2007 - Elsevier
Objective To evaluate the prevalence of classic and nonclassic cardiovascular risk factors in
patients with acromegaly. Methods Sixty-two patients with acromegaly (50 with active …

Pathogenesis, clinical and laboratory aspects of thrombosis in cancer

M Franchini, M Montagnana, G Targher… - Journal of thrombosis …, 2007 - Springer
The relationship between increased clotting and malignancy is well recognized, though the
bidirectional development of this association is often overlooked. In the challenging cancer …

Relation between hemostatic parameters and prognostic/predictive factors in breast cancer

E Yigit, G Gönüllü, İ Yücel, M Turgut, D Erdem… - European journal of …, 2008 - Elsevier
BACKGROUND: In our study, we searched for a relation between various prognostic and
predictive factors and hemostatic parameters. METHODS: One hundred women with newly …

[HTML][HTML] Increased acquired activated protein C resistance in unselected patients with hematological malignancies

HFS Negaard, PO Iversen, B Østenstad… - Journal of Thrombosis …, 2008 - Elsevier
Background: We have previously found that activation of coagulation in patients with various
hematological malignancies was apparently not initiated by tissue factor (TF). Acquired …

The serpin solution; targeting thrombotic and thrombolytic serine proteases in inflammation

H Chen, J A. Davids, D Zheng, M Bryant… - Cardiovascular & …, 2013 - benthamdirect.com
Serpins in the mammalian body are highly potent serine protease inhibitors which modulate
both thrombotic and thrombolytic pathway activation, with direct and indirect crosstalk with …

Proteomic analysis of childhood de novo acute myeloid leukemia and myelodysplastic syndrome/AML: correlation to molecular and cytogenetic analyses

M Braoudaki, F Tzortzatou-Stathopoulou… - Amino acids, 2011 - Springer
The aim of this study was to investigate the progression of myelodysplastic syndrome (MDS)
to acute myeloid leukemia (AML) and to provide additional data regarding the proteomic …

Can biomarkers of coagulation, platelet activation, and inflammation predict mortality in patients with hematological malignancies?

S Elmoamly, A Afif - Hematology, 2018 - Taylor & Francis
Background: Patients with cancer commonly demonstrate laboratory evidence for
hypercoagulability. Coagulation and inflammation play a role in the pathophysiology of …

[PDF][PDF] Classification and clinical manifestations of the clonal myeloid disorders

MA Lichtman - Williams Hematology. 6th ed. New York: McGraw …, 2001 - thesilverfridge.com
The clonal myeloid neoplasms result from acquired driver and cooperating mutations within
a multipotential marrow cell, or sometimes, perhaps, a stem cell. Translocations, inversions …